Correlation Engine 2.0
Clear Search sequence regions


  • acetate (10)
  • cases (1)
  • emergency (2)
  • endometrium (4)
  • female (1)
  • human (2)
  • luteal phase (1)
  • norpregnadienes (2)
  • women (3)
  • Sizes of these terms reflect their relevance to your search.

    To analyse the effect of ulipristal acetate (UPA) as emergency contraception (EC) on the gene expression of human endometrial cell line (HEC-1A) and endometrium from fertile women treated with UPA after ovulation. HEC-1A cells were treated with UPA, and endometrial tissue from four healthy women was collected in cycles before, during and 2 months after post-ovulation pill intake. Ovulation and luteal phase were monitored, and endometrial biopsies were obtained at day LH + 7 in each cycle. In all cases, we analysed the expression profile of 192 genes associated to endometrial receptivity. We observed a significant change in total transcriptomic activity of UPA-treated HEC-1A cells compared to controls. In vivo, we also observed a trend to down-regulation of genes in the UPA-treated cycle that was partially restored in the post-treatment cycle. Altogether, our results supported a partially reversible effect of UPA in gene expression associated with uterine receptivity. When UPA was administered after ovulation, it seems to induce a down-regulation of the main genes involved in conditioning the endometrium for implantation. This effect is partially restored two months after pill intake. The action of UPA on the endometrium for users of EC should be further investigated.

    Citation

    Maripaz Jiménez Guerrero, Mariana Fava, Luiz F Baccaro, Adriana M Caille, Patricia S Cuasnicú, José A Horcajadas, Débora J Cohen, Luis Bahamondes, David Cotán, María José Munuce. Effect of ulipristal acetate on gene expression profile in endometrial cells in culture and in vivo upon post-ovulatory administration in fertile women. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception. 2022 Jun;27(3):199-207

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 34486904

    View Full Text